Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Butzkueven H, Trojano M, Kappos L, Spelman T, et al. Clinical outcomes in patients who discontinue natalizumab therapy after 2 years in the Tysabri((R)) Observational Program (TOP). Mult Scler 2021;27:410-419.
PMID: 32406786


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016